Inhibition of LRP6 by miRNA‐454 in pancreatic ductal adenocarcinoma exerted antiangiogenic and antimetastatic effects (Fan et al., 2017). This evidence concerns the gene LRP6 and pancreatic ductal adenocarcinoma.